Workshop on DHA as a required nutrient: Overview

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 2-3, 2009, Pages 233-236

  Saldanha, Leila G ^a   Salem Jr , Norman ^b   Brenna, J Thomas ^c  

^a NutrIQ LLC   (United States)

^b Martek Biosciences Corporation   (United States)

^c Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID EMULSION; OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CHILD DEVELOPMENT; CLINICAL TRIAL; DIET SUPPLEMENTATION; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID SYNTHESIS; HUMAN; ISCHEMIC HEART DISEASE; NERVOUS SYSTEM DEVELOPMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL VALUE; PARENTERAL NUTRITION; PHENYLKETONURIA; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; DIET; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL REQUIREMENTS; PREGNANCY;

EID: 69549088016     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.07.001     Document Type: Article

References (29)

1. Salem Jr. N. Omega-3 fatty acids: molecular and biochemical aspects. In: Spiller G., and Scala J. (Eds). New Protective Roles of Selected Nutrients in Human Nutrition (1989), Alan R. Liss, New York 109-228
2. A.T. Hsieh, J.T. Brenna, Dietary docosahexaenoic acid but not arachidonic acid influences central nervous system fatty acid status in baboon neonates, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.012.
3. P.M. Kris-Etherton, J.A. Grieger, T.D. Etherton, Dietary reference intakes for DHA and EPA Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.011.
4. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients) (2009), National Academy Press, Washington, DC. http://books.nap.edu/openbook.php?isbn=0309085373 Available at: 〈http://books.nap.edu/openbook.php?isbn=0309085373〉. Accessed July 4
5. Institute of Medicine. How Should the Recommended Dietary Allowances be Revised? (1994), National Academy Press, Washington, DC. http://books.nap.edu/openbook.php?record_id=9194&page=1 Available at: 〈http://books.nap.edu/openbook.php?record_id=9194&page=1〉. Accessed July 4, 2009
6. J. Whelan, L. Jahns, K. Kavanagh-Prochaska, Docosahexaenoic acid measurements in food and dietary exposure, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.008.
7. J.T. Brenna, N. Salem, Jr., A.J. Sinclair, S.C. Cunnane, For the international society for the study of fatty acids and lipids, ISSFAL, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, in press, doi:10.1016/j.plefa.2009.01.004.
8. S.I. Rapoport, M. Igarashi, Can the liver maintain normal brain DHA and metabolism in the absence of dietary DHA?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.021.
9. C.N. Kuratko, N. Salem, Jr., Biomarkers of DHA status, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.007.
10. Muskiet F.A.J., Fokkema M.R., Schaafsma A., Boersma E.R., and Crawford M.A. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. Journal of Nutrition 134 (2004) 183-186
11. T.A.B. Sanders, DHA status of vegetarians.Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.013.
12. B. Koletzko, S. Beblo, H.W. Müller-Felber, F.L. Hanebutt, Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.06.006.
13. H.D. Le, K.M. Gura, J.A. Meisel, V.E. de Meijer, M. Puder. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.020.
14. A. Lapillonne, C.L. Jensen. Reevaluation of the DHA requirement for the premature infant. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.014.
15. M. Makrides, Is there a dietary requirement for DHA in pregnancy?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.005.
16. Brenna J.T., Varamini B., Jensen R.G., Diersen-Schade D.A., Boettcher J.A., and Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. American Journal of Clinical Nutrition 85 (2007) 1457-1464
17. D.R. Hoffman, J.A. Boettcher, D.A. Diersen-Schade, Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.003.
18. Makrides M., Gibson R.A., McPhee A.J., Collins C.T., Davis P.G., Doyle L.W., Simmer K., Colditz P.B., Morris S., Smithers L.G., Willson K., and Ryan P. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. Journal of the American Medical Association 301 2 (2009) 175-182
19. Diau G.Y., Loew E.R., Wijendran V., Sarkadi-Nagy E., Nathanielsz P.W., and Brenna J.T. Docosahexaenoic and arachidonic acid influence on preterm baboon retinal composition and function. Investigative Ophthalmology and Visual Science 44 10 (2003) 4559-4566
20. Fedorova I., Hussein N., Di Martino C., Moriguchi T., Hoshiba J., Majchrzak S., and Salem Jr. N. An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze. Prostaglandins Leukotrienes and Essential Fatty Acids 77 (2007) 269-277
21. C.L. Jensen, A. Lapillonne, Docosahexaenoic acid and lactation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.006.
22. B.J. Holub, Docosahexaenoic acid (DHA) and cardiovascular disease risk factors. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.016.
23. C. von Schacky, Cardiovascular disease prevention and treatment. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.009.
24. R.S. Chapkin, W. Kim, J.R. Lupton, D.N. McMurray, Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.010.
25. N.G. Bazan, Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.024.
26. G.M. Cole, Q.-L. Ma, S.A. Frautschy, Omega-3 fatty acids and dementia. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.015.
27. R.K. McNamara, Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.017.
28. J.R. Hibbeln, J.M. Davis, Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.06.005.
29. E.L. Lien, Toxicology and safety of DHA. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, this issue, doi:10.1016/j.plefa.2009.05.004.